|
Volumn 43, Issue 5, 2008, Pages 511-513
|
Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure
|
Author keywords
Betalactam antibiotics; Continuous infusion; Cystic fibrosis; Eradication; Pseudomonas aeruginosa; Tobramycin
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AZTREONAM;
BETA LACTAM ANTIBIOTIC;
CEFEPIME;
CEFTAZIDIME;
CIPROFLOXACIN;
MEROPENEM;
PIPERACILLIN PLUS TAZOBACTAM;
TOBRAMYCIN;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
BACTERIAL COLONIZATION;
BACTERIUM ISOLATE;
CASE REPORT;
CONTINUOUS INFUSION;
CYSTIC FIBROSIS;
DISEASE EXACERBATION;
DRUG MEGADOSE;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ERADICATION THERAPY;
FEMALE;
GRAM NEGATIVE INFECTION;
HOSPITAL ADMISSION;
HUMAN;
INFANT;
MINIMUM INHIBITORY CONCENTRATION;
OUTPATIENT CARE;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
THROAT CULTURE;
TREATMENT DURATION;
TREATMENT FAILURE;
AMINOGLYCOSIDES;
ANTI-BACTERIAL AGENTS;
AREA UNDER CURVE;
BETA-LACTAMS;
CYSTIC FIBROSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INFANT;
INFUSIONS, INTRAVENOUS;
INPATIENTS;
OUTPATIENTS;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 43249101969
PISSN: 87556863
EISSN: 10990496
Source Type: Journal
DOI: 10.1002/ppul.20791 Document Type: Article |
Times cited : (13)
|
References (9)
|